AgriCann Announces Resignation of Chief Financial Officer
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2024) - AgriCann Solutions Corp. ("AgriCann") (with its subsidiaries, collectively referred to as...
Year: 2024
CLOUD DX Appoints New Board Member
Mr. Konstantin Othmer, a Technologist and Angel Investor, Joins the Board.News in SummaryCloud DX is pleased to welcome Mr. Konstantin...
American Society for Transplantation and Cellular Therapy Awards Robin Roberts With the 2024 Public Service Award
The annual award honors Roberts' special service to the patients and families that are served by the ASTCT community.CHICAGO, IL...
Red Light Holland and PharmAla to Collaborate on Medical Psilocybin Development
PharmAla will consult on GMP Drug Product and Regulatory Development for Red Light Holland Toronto, Ontario--(Newsfile Corp. - February 9,...
ProCell(R) Receives CE Marked Approval for Selling Into the European Union
BOSTON, MA / ACCESSWIRE / February 9, 2024 / ProCell® Surgical Inc. has successfully been registered and is certified to...
Autonomix Medical, Inc. (NASDAQ:AMIX) to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference
Webcast presentation on Wednesday, February 14th at 10:30 AM ESTTHE WOODLANDS, TX / ACCESSWIRE / February 9, 2024 / Autonomix...
Caira Surgical to Present Innovative Radar Surgical Tracking at CG 2024 Musculoskeletal Conference
CEO Jon Greenwald to Present at 4:30 p.m. in the Georgian Room Jon Greenwald, Chief Executive Officer at Caira Surgical...
Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences
Fort Lee, NJ, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage...
Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights
- Year-over-year revenue increased 114% for the fiscal second quarter and 337% for the six-months ending December 31, 2023 -...
PharmAla and Red Light Holland to Collaborate on Medical Psilocybin Development
PharmAla will consult on GMP Drug Product and Regulatory Development for Red Light HollandVANCOUVER, British Columbia, Feb. 09, 2024 (GLOBE...
MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor Conferences
ROCKVILLE, Md., Feb. 09, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing...
OneMedNet Sees Real World Data Growth in Women’s Health
MINNEAPOLIS, Feb. 09, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade...
Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma
– BLA submission supported by results from Phase 2/3 clinical trial and outcomes of real-world use of the HAV under...
Performance Health Systems and HPN Holdings Execute Letter of Intent to Merge
Northbrook, Illinois--(Newsfile Corp. - February 9, 2024) - Performance Health Systems LLC, the manufacturer and distributor of Power Plate ®...
Invitation to Senzime’s Fourth Quarter 2023 Report Presentation
UPPSALA, SWEDEN / ACCESSWIRE / February 9, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast...
iZafe Group’s Year-end Report, October-December 2023
STOCKHOLM, SWEDEN / ACCESSWIRE / February 9, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group AB (publ.) presents today, February 9,...
New Peer-Reviewed Study Finds That Masimo SET® Pulse Oximetry Measures Accurately on Both Black and White People Even During Low Perfusion
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of a retrospective, peer-reviewed study published in the Journal of Clinical...
Intellipharmaceutics International Inc. Announces Stock Option Grant
TORONTO, ON / ACCESSWIRE / February 8, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company...
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results
Revenues increased 7% compared to quarter from prior year and 15% from prior quarterImprovement in gross margin for quarter of...
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
- Company On Track to Initiate First-Phase GMP Production Capacity for mRNA Critical Starting Materials During First Half of Calendar...